David Abramson, MD

In addition to serving as chief of ophthalmic oncology at Memorial Sloan Kettering Cancer Center, Abramson is also a tenured professor in surgery, pediatrics and radiation oncology there and a professor of ophthalmology at Weill Cornell Medicine in New York City. His lists of "first to do" is large and includes the introduction of PGD (pre-implantation genetic diagnosis) for eye cancers, introduction of the use of the diopexy for retinoblastoma, delivery of chemotherapy via peri-ocular injection for retinoblastoma and many others. He has performed nearly 10,000 operations and laser procedures, and was inducted into the first class of inductees by the International Retina Hall of Fame for his contribution to retinal diseases. A clinician-scientist, he has delivered more than 500 lectures around the world and also published more than 800 articles and books, with his publications being cited more than 30,000 times. Abramson was the principal investigator of the nationwide COMS s